Realize the Potential of Genomic Data in Drug Development
Ovation offers a consented biobank of ~1.6 million samples that can be sequenced to generate genomic data across more than 60 pre-defined disease cohorts
Consented samples (Sample types include FFPE tissue, nasopharyngeal swabs, preserved saliva, whole blood, total nucleic, and more)
Unique patients
Pre-defined disease cohorts
Samples are sequenced to deliver:
- Whole genome sequencing data (30X depth)
- Whole exome sequencing data
- RNA sequencing data
- And more
Cohorts are curated through linkage to phenotypic data using common tokens.
Phenotypic and clinical data including treatment exposure, comorbidities, lab values, and disease severity metrics from top claims, EHR, and lab real-world data sources is linked to omics data from Ovation’s database.
Learn more about how your organization can use Ovation’s omics data to accelerate R&D
For an expert consultation on how we can work together,
complete this form and we’ll be in touch soon.
Explore more about
Ovation’s Data Products
Webinar
Linking Genomic and Phenotypic Data to Understand the Patient Journey
Data in Action
Ovation’s Poster from the 2024 Crohn’s & Colitis Congress
Thought Leadership
Ovation Presents at the 2023 AWS Life Sciences Executive Symposium